AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
How a big biotech’s start-up gamble went wrong
Behind the Money
The History of Illumina's Acquisition of Grail
In 2017, Illumina spun this new cancer screening company out onto its own. They got more than two billion of investment from the likes of Bill Gates and Jeff Bezos. By 2020, the data that Grail was producing for its tests was looking good. And Illumina, Grail's former home, was taking notice. So it actually bought back Grail for $8 billion.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode